How much funding has Veeva Systems raised?

Veeva Systems has raised $7M in total funding. Their latest funding round was IPO. Key investors include Emergence Capital, Lead Edge Capital.

Where is Veeva Systems headquartered?

Veeva Systems is headquartered in Pleasanton, California, United States.

When was Veeva Systems founded?

Veeva Systems was founded in 2007. It is based in Pleasanton, California, United States.

How much funding has Veeva Systems raised?

Veeva Systems has raised $7M in total funding. Key investors include Emergence Capital, Lead Edge Capital.

Who is the CEO of Veeva Systems?

Peter Gassner is the CEO of Veeva Systems. The company was founded in 2007.

Where is Veeva Systems located?

Veeva Systems is headquartered in Pleasanton, California, United States.

What funding stage is Veeva Systems at?

Veeva Systems is currently at the Public stage.

Veeva Systems

Category: AI in Healthcare

Veeva Systems is the industry cloud for life sciences, providing cloud-based software, data, AI, and consulting services purpose-built for pharmaceutical and biotech companies. Veeva Systems was founded in 2007. The company is led by Peter Gassner. Based in Pleasanton, California, United States. Total funding raised: $7M. Latest round: IPO. Key investors include Emergence Capital, Lead Edge Capital.

Founded: 2007
Headquarters: Pleasanton, California, United States
Total funding: $7M

Value proposition

Purpose-built cloud for the entire life sciences value chain — from R&D and clinical trials through regulatory, quality, safety, medical, and commercial — all on a unified platform compliant with FDA/GxP regulations. Veeva's solutions are designed specifically for the pharmaceutical industry, not adapted from generic enterprise software.

Products and solutions

Veeva Development Cloud (Clinical: eTMF, CTMS, EDC, RTSM, Study Startup, Site Connect, Regulatory: RIM, Submissions, Safety: Adverse Event management, SafetyDocs, Safety Signal), Veeva Quality Cloud (QualityDocs, QMS, Training, Batch Release, LIMS), Veeva Commercial Solutions (Vault CRM, Ostro AI agent, Campaign Manager, Events Management), Veeva AI (Agentic AI built into Vault Platform, Falcon agentic platform for drug development), Veeva Data Cloud (OpenData, Link, Compass), Veeva Medical Solutions

Unique value

The only end-to-end industry cloud built natively for life sciences, spanning clinical development, regulatory, quality, safety, medical, and commercial — with deep domain expertise, regulatory compliance baked in, and a public benefit corporation structure. The new Falcon AI agent platform brings agentic labor to drug development processes.

Target customer

Pharmaceutical and biotechnology companies of all sizes — from the world's largest pharma (top 20 global pharma) to emerging biotechs, as well as contract research organizations (CROs), medical device companies, and consumer health organizations.

Industries served

Life Sciences (Pharma & Biotech), MedTech, Consumer Packaged Goods, Food & Beverage, Chemical, Animal Health

Technology advantage

Veeva Vault Platform (multi-tenant cloud platform for life sciences); Veeva AI with agentic AI built into the platform; AWS-powered global infrastructure with 10+ year partnership; AI agents (Falcon) purpose-built for drug development; Veeva CRM on Salesforce platform (migrating to Vault CRM post-Salesforce partnership end); comprehensive data assets (OpenData, Link, Compass); compliance-first architecture for regulated environments.

How they differentiate

Industry specialization vs horizontal SaaS: Veeva is purpose-built for life sciences with regulatory compliance built-in (FDA, GxP, HIPAA). Deep domain expertise across the full drug lifecycle. 10+ year AWS partnership. Public benefit corporation structure. Most comprehensive life sciences cloud with 1,500+ customers. The Falcon AI agent platform is purpose-built for drug development processes with pre-built agents for clinical, regulatory, and safety workflows.

Main competitors

Salesforce (Life Sciences Cloud / Health Cloud), IQVIA (Orchestrated Customer Engagement / OCE), Medidata (Dassault Systèmes — clinical cloud), Oracle Health Sciences

Key partnerships

AWS (10+ year strategic partnership for cloud infrastructure), AI Partner Directory with ecosystem of AI partners, Content Partners, CRO Partners, Data Partners

Notable customers

Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Pfizer, Johnson & Johnson, AstraZeneca, GlaxoSmithKline (GSK), Amgen, AbbVie

Major milestones

2007: Founded by Peter Gassner and Matt Wallach, 2011: Launched Veeva Vault (content management for life sciences), 2013: IPO on NYSE (VEEV), raised $217M, shares nearly doubled on debut, 2021: Became first publicly traded company to convert to a Public Benefit Corporation, 2024-2025: Ended Salesforce partnership, transitioned to Vault CRM, 2026: Announced Falcon AI agent platform for drug development (early adopter availability November 2026), 2026: Acquired Ostro ($100M) for AI-powered patient and HCP engagement, FY2026: Revenue $3.195B, 7,928 employees, S&P 500 component

Growth metrics

FY2026 Revenue: $3.195B (16% YoY growth); Net Income: $908M; Market Cap: ~$30B; Employees: 7,928; Revenue/Employee: ~$403K; Customers: 1,500+

Market positioning

Market leader in life sciences cloud software — the dominant vertical SaaS player in pharma with $3.2B revenue and ~$30B market cap. Publicly traded (NYSE: VEEV), S&P 500 component. Competes with horizontal players (Salesforce, Oracle) and other life sciences specialists (IQVIA, Medidata/Dassault). Recently ended Salesforce partnership to go independent with Vault CRM.

Geographic focus

Global — HQ in Pleasanton, CA with operations in North America, Europe, Asia Pacific (Japan, China, Korea).

About Peter Gassner

IBM (database developer); PeopleSoft (Chief Architect & VP/GM of PeopleTools, 9 years); Salesforce (SVP of Technology, 4 years). Education: Oregon State University.

Official website: https://www.veeva.com